title: [New promising treatments of Ebola virus disease are underway].
abstract: The largest Ebola epidemic ever is about to end. No major breakthrough in terms of specific treatment has been seen, but a number of valuable lessons have been learned, including the potential of intensive supportive care. New products are under development, but clinical trials were initiated late in the epidemic leading to inability to include sufficient numbers. Several large vaccine trials are underway with one vaccine so far showing 100 per cent efficacy. A paradigm shift in accelerated testing of drugs and vaccines during an ongoing epidemic is emerging.
authors.affiliation: sanne.jespersen@clin.au.dk.
authors.forename: Sanne
authors.initials: S
authors.lastname: Jespersen
authors.forename: Cecilie Norup
authors.initials: CN
authors.lastname: Thomsen
authors.forename: Christian
authors.initials: C
authors.lastname: Wejse
authors.forename: Merete
authors.initials: M
authors.lastname: Storgaard
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D046129:Ebola Vaccines / Q000494:pharmacology; D029043:Ebolavirus; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D006801:Humans
chemical_list: D000998:Antiviral Agents; D046129:Ebola Vaccines